First Trust Nasdaq Pharmaceuticals ETF (FTXH) Dividend Yield, History & Forecast

First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund (ETF) listed on the NASDAQ Global Market. It pays a current dividend yield of 0.66% ($0.29 per share annually (TTM)). The most recent ex-dividend date was September 24, 2026, with payment scheduled for September 30, 2026. market capitalization is approximately $1.19B. Review FTXH dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

FTXH fund composition

FTXH holds 50 positions, with 56.0% of assets in its ten largest. It charges an expense ratio of 0.60%, and manages $1.18B.

Top 10 holdings

HoldingWeight
LLYEli Lilly and Company8.22%
ABBVAbbVie Inc.7.71%
PFEPfizer Inc.7.19%
JNJJohnson & Johnson6.89%
MRKMerck & Co., Inc.6.78%
BIIBBiogen Inc.3.92%
GILDGilead Sciences, Inc.3.91%
REGNRegeneron Pharmaceuticals, Inc.3.89%
VTRSViatris Inc.3.86%
AMGNAmgen Inc.3.63%

Sector allocation

Healthcare100.0%

Frequently Asked Questions about First Trust Nasdaq Pharmaceuticals ETF (FTXH)

What is First Trust Nasdaq Pharmaceuticals ETF's dividend yield?
First Trust Nasdaq Pharmaceuticals ETF (FTXH) pays a current trailing twelve-month dividend yield of 0.66%, which works out to $0.29 per share annually based on the most recent payout schedule.
When does First Trust Nasdaq Pharmaceuticals ETF pay distributions?
The most recent ex-dividend date was September 24, 2026. The next scheduled dividend payment date is September 30, 2026.
How many years has First Trust Nasdaq Pharmaceuticals ETF increased its dividend?
First Trust Nasdaq Pharmaceuticals ETF (FTXH) has increased its dividend for 8 consecutive years.
What does First Trust Nasdaq Pharmaceuticals ETF invest in?
The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within that index, striving for a performance correlation of at least 95%.